Lead Product(s) : Hyaluronic Acid,Collagen,Dermatan Sulfate
Therapeutic Area : Dermatology
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
New Study Reveals Bioiberica's Dermial® Delivers Superior Benefits for Skin Health
Details : New pre-clinical study showed that Dermial® hyaluronic acid matrix ingredient increased type I collagen production by almost half – an observation not seen with standard hyaluronic acid from fermentation or extraction origin.
Product Name : Dermial
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 25, 2022
Lead Product(s) : Hyaluronic Acid,Collagen,Dermatan Sulfate
Therapeutic Area : Dermatology
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : KMN-159,Collagen
Therapeutic Area : Musculoskeletal
Study Phase : Preclinical
Sponsor : NIDCR
Deal Size : $1.7 million
Deal Type : Funding
Cayman Receives Grant to Evaluate Use of KMN-159 to Accelerate Dental Implant Osseointegration
Details : The grant will be used to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage of dental titanium implants into the jawbone.
Product Name : KMN-159
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
September 16, 2021
Lead Product(s) : KMN-159,Collagen
Therapeutic Area : Musculoskeletal
Highest Development Status : Preclinical
Sponsor : NIDCR
Deal Size : $1.7 million
Deal Type : Funding
Reset All
Bioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.
